InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (1 ops.)
Browse the full record of transactions filed by KARINE LIGNEL, Administratrice. Officer active across 2 companies, notably Oncodesign Precision Medicine S.A.. Cumulatively, 6 disclosures have been published. Total volume traded: €1.1m. The latest transaction was disclosed on 12 December 2022 — Acquisition. Regulator: AMF. All data is openly available.
Declarations6 total
€164,000200,000 shares@ €0.821.26% mcap100.0% of flow
ActionHors plateforme de négociation
2022DD876588·
Ideal exit: 8 Sept 2023 (T+270)
€399,72227,720 shares@ €14.423.08% mcap42.6% of flow
ActionHors plateforme de négociation
2022DD867441·
€184,80018,480 shares@ €10.001.42% mcap19.7% of flow
ActionEuronext Paris
2022DD865669·
Ideal exit: 4 Jul 2023 (T+270)
€184,80018,480 shares@ €10.001.42% mcap19.7% of flow
ActionEuronext Paris
2022DD866014·
Ideal exit: 4 Jul 2023 (T+270)
€84,4069,240 shares@ €9.13480.65% mcap9.0% of flow
ActionEuronext Paris
2022DD839952·
Ideal exit: 23 Jan 2023 (T+270)
€84,4069,240 shares@ €9.13480.65% mcap9.0% of flow
ActionEuronext Growth Paris
2022DD841853·
Ideal exit: 23 Jan 2023 (T+270)
6 of 6 declarations
About KARINE LIGNEL
Karine Lignel is a Board Member and Deputy Chief Executive Officer at Oncodesign and Oncodesign Precision Medicine S.A. In this role, she participates in the strategic decisions of the board and contributes to the governance of the companies. Karine brings her expertise in research and innovation, which is essential for guiding Oncodesign in its growth initiatives.
